Early research (Phase 1)Study completedNCT02239146
What this trial is testing
Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass
Who this might be right for
Acquired Bleeding DisorderCardiac Surgery Requiring Cardiopulmonary Bypass
Novo Nordisk A/S 43